About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNANCT03545217

Abnormal Glucose Metabolism in HIV-infected Patients

HIV is a major health problem worldwide especially in low-to middle-income countries including Thailand. Fortunately, a significant reduction in morbidity and mortality has been observed due to the us...

Lead sponsor: Mahidol University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Somnuek Sungkanuparph, MD

CONTACT

+6622011581 [email protected]

Sirimon R Pratuangtham, MD

CONTACT

[email protected]

Sponsors

Lead Sponsor

Mahidol University

Collaborators

University of Illinois at Chicago

Age

35 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•HIV-infected patients, age 35-65 years old
•Receiving antiretroviral therapy
•Diagnosis of prediabetes (hemoglobin A1c, HbA1c levels ≥5.7-\<6.5% and fasting glucose levels \<126 mg/dl and 2-hour glucose levels \<200 mg/dl following 75-gram OGTT)

Exclusion Criteria

•Serious medical problems (stroke with significant disability, estimated glomerular filtration rate \<45 ml/min/1.73 m2, uncontrolled congestive heart failure, symptoms suggestive of untreated cardiopulmonary disease such as chest pain or shortness of breath, significant anemia defined as hemoglobin \<9.0 g/dL, severe pulmonary disease including those requiring home oxygen therapy, end stage liver disease)
•A previous diagnosis of diabetes
•Currently diagnosed with contagious infectious disease
•Pregnancy

Related studies

n-3 PUFAs, Irisin and Maternal Glucose Metabolism From Pregnancy to Postpartum

NCT03023293 · Gestational Diabetes Mellitus, Neurodevelopmental Disorders, and more

COMPLETEDPhase 2

Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations

NCT02457897 · Insulin Resistance, Diabetes Mellitus, and more

Effects of Urinary Kallidinogenase in Acute Ischemic Stroke Patients With Abnormal Glucose Metabolism

NCT04020666 · Acute Ischemic Stroke, Abnormal Glucose Metabolism

TERMINATEDPhase 4

Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion

NCT00150085 · Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 4, 2018Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment75

Start dateJul 2017

Last updatedJun 4, 2018

Condition

Abnormal Glucose Metabolism

Locations shown

Faculty of Medicine Ramathibodi Hospital, Mahidol University

Bangkok

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 4, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions